Company page
Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. (IMDX) is a public company operating in the American market, with a market capitalization of approximately $175.66 million. The company focuses on developing innovative diagnostic solutions. Its commitment to advancing molecular diagnostics positions it as a key player in the healthcare industry.

- Ticker
- IMDX:NASDAQ
- Asset type
- Stock
- Market cap
- $175.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD